Alpha-synuclein kinase

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01)

Patent

CA 2641219

The invention provides agents and methods for treatment of diseases associated with Lewy body diseases (LBDs) in the brain of a patient. Preferred agents include inhibitors of PLK2 and GRK6 kinases.

L'invention concerne des agents et des méthodes de traitement de maladies associées aux maladies à corps de Lewy (LBD) dans le cerveau d'un patient. Les agents préférs comprennent des inhibiteurs des PLK2 et GRK6 kinases.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Alpha-synuclein kinase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Alpha-synuclein kinase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alpha-synuclein kinase will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1790182

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.